Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maryland
Pharma
AZ brings its cell therapy ambitions to MD with $300M investment
Following a slew of cell therapy biotech team-ups, AstraZeneca is taking manufacturing into its own hands.
Fraiser Kansteiner
Feb 6, 2024 10:05am
Gilead assembles CAR-T manufacturing troika with new FDA nod
Apr 19, 2022 10:45am
FDA scolds Jubilant in the first public Form 483 in months
Aug 23, 2021 11:15am
BioNTech is taking over a Kite Pharma cell therapy plant in MD
Jul 19, 2021 11:01am
Humanigen taps Emergent for fill-finish work on antibody hopeful
Jan 26, 2021 8:10am
Maryland, Massachusetts push pricing bills over pharma protests
Apr 12, 2019 11:05am